Literature DB >> 21404263

Improving N-glycosylation efficiency in Escherichia coli using shotgun proteomics, metabolic network analysis, and selective reaction monitoring.

Jagroop Pandhal1, Saw Yen Ow, Josselin Noirel, Phillip C Wright.   

Abstract

Recently, the prospect of using Escherichia coli as a host for human glycoprotein production has increased due to detailed characterization of the prokaryotic N-glycosylation process and the ability to transfer the system into this bacterium. Although functionality of the native Campylobacter jejuni N-glycosylation system in E. coli has been demonstrated, the efficiency of the process using the well-characterized C. jejuni glycoprotein AcrA, was found to be low at 13.4±0.9% of total extracted protein. A combined approach using isobaric labeling of peptides and probability-based network analysis of metabolic changes was applied to forward engineer E. coli to improve glycosylation efficiency of AcrA. Enhancing flux through the glyoxylate cycle was identified as a potential metabolic manipulation to improve modification efficiency and was achieved by increasing the expression of isocitrate lyase. While the overall recombinant protein titre did not change significantly, the amount of glycosylated protein increased by approximately 300%.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21404263     DOI: 10.1002/bit.23011

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  18 in total

Review 1.  Proteomics dedicated to biofilmology: What have we learned from a decade of research?

Authors:  Arbia Khemiri; Thierry Jouenne; Pascal Cosette
Journal:  Med Microbiol Immunol       Date:  2015-06-12       Impact factor: 3.402

Review 2.  Bacterial protein N-glycosylation: new perspectives and applications.

Authors:  Harald Nothaft; Christine M Szymanski
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

Review 3.  Mass spectrometry-based proteomics: qualitative identification to activity-based protein profiling.

Authors:  Job D Cardoza; Jignesh R Parikh; Scott B Ficarro; Jarrod A Marto
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-01-09

Review 4.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

5.  Comparative characterization of the glycosylation profiles of an influenza hemagglutinin produced in plant and insect hosts.

Authors:  Sheng Zhang; Robert W Sherwood; Yong Yang; Tara Fish; Wei Chen; James A McCardle; R Mark Jones; Vidadi Yusibov; Eliel Ruiz May; Jocelyn K C Rose; Theodore W Thannhauser
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

6.  Quantitative proteomic comparison of salt stress in Chlamydomonas reinhardtii and the snow alga Chlamydomonas nivalis reveals mechanisms for salt-triggered fatty acid accumulation via reallocation of carbon resources.

Authors:  E Hounslow; C A Evans; J Pandhal; T Sydney; N Couto; T K Pham; D James Gilmour; P C Wright
Journal:  Biotechnol Biofuels       Date:  2021-05-22       Impact factor: 6.040

7.  Systematic metabolic engineering for improvement of glycosylation efficiency in Escherichia coli.

Authors:  Jagroop Pandhal; Pratik Desai; Caroline Walpole; Leyla Doroudi; Dmitry Malyshev; Phillip C Wright
Journal:  Biochem Biophys Res Commun       Date:  2012-02-10       Impact factor: 3.575

8.  An inverse metabolic engineering approach for the design of an improved host platform for over-expression of recombinant proteins in Escherichia coli.

Authors:  Chaitali Ghosh; Rashmi Gupta; Krishna Jyoti Mukherjee
Journal:  Microb Cell Fact       Date:  2012-07-03       Impact factor: 5.328

Review 9.  Strain engineering for improved expression of recombinant proteins in bacteria.

Authors:  Tomohiro Makino; Georgios Skretas; George Georgiou
Journal:  Microb Cell Fact       Date:  2011-05-14       Impact factor: 5.328

10.  Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines.

Authors:  Emily J Kay; Marta Mauri; Sam J Willcocks; Timothy A Scott; Jon Cuccui; Brendan W Wren
Journal:  Microb Cell Fact       Date:  2022-04-21       Impact factor: 6.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.